Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence TGARGLVGEpGpAGSKGESGNKGEpGSAGPQ
Primary information
sequence IDSeq_8169
Peptide sequenceTGARGLVGEpGpAGSKGESGNKGEpGSAGPQ
CancerPDF_ID CancerPDF_ID3504, CancerPDF_ID3776,
PMID27026199,27026199
Protein NameCollagen alpha-2(I) chain,Collagen alpha-2(I) chain
UniprotKB Entry NameCOL1A2_HUMAN,CO1A2_HUMAN
FluidUrine,Urine
M/ZNA,NA
ChargeNA,NA
Mass (in Da)NA,NA
fdr2853.33,2853.3
Profiling Technique"CE-MS, Micro-TOF-MS","CE-MS, Micro-TOF-MS"
Peptide Identification techniqueMS-MS,MS-MS
Quantification TechniqueNA,NA
Labelled/Label FreeLabel Free,Label Free
FDRNA,NA
CancerPDF_ID CancerPDF_ID3504, CancerPDF_ID3776,
p-Valueless than 0.05,2.80E-04
SoftwareProteome Discoverer 1.2,Proteome Discoverer 1.2
Length31,31
Cancer TypeBladder cancer,Bladder cancer
DatabaseUniprot Human non-redundant Database,Uniprot Human non-redundant Database
Modificationp:Hydroxy-Proline,p:Hydroxy-Proline
Number of Patients451 for training (341 patients and 110 normal) and 270 for testing(168 primary UBC patients and 102 normal controls);, 425 for training(109 patients with Recurrent UBC cases and 316 negative for recurrence controls) and 211 for validation (55 UBC recurrent cases and 156 recurrent controls)
RegulationDifferentially expressed between primary UBC and normal individual,Differentially expressed between recurrence of UBC vs recurrence control
ValidationIndependent Validation,Independent Validation
SensitivityFor testing dataset 91%,For testing dataset 88%
SpecificityFor testing dataset 68%,For testing dataset 51%
AccuracyFor testing dataset 76%,NA
Peptide AtlasNA
IEDB